Active psoriasis was associated with, and potentially a cause of, poorer QoL in patients with PsA, even those with mild disease. PsA made a greater disease impact on women than men in this review, a ...
—Researchers in Canada compared isolated axial psoriatic arthritis, axial PsA with peripheral involvement, and isolated axial ankylosing spondylitis with psoriasis, to determine which factors predict ...
Please provide your email address to receive an email when new articles are posted on . Although a range of biologic options are available to clinicians treating psoriatic arthritis, it crucial to ...
Almost two thirds (64%) of patients with psoriatic arthritis (PsA) who were receiving tumor necrosis factor alpha (TNFα) inhibitors achieved a state of minimal disease activity (MDA), according to a ...
Clinical Trials Arena on MSN
Three PSA trials to watch in 2026
As rheumatologists prepare for EULAR 2026, Clinical Trials Arena takes a look at the most promising drugs in late-stage ...
Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Understanding which psoriatic arthritis disease domains are most important to the patient may ...
Extended follow-up data from the ProtecT trial highlight the importance of weighing the risks associated with radical treatment versus active surveillance for newly diagnosed localized prostate cancer ...
Being in perimenopause was significantly associated with higher psoriatic arthritis disease activity scores when compared with the pre- and postmenopausal stages. Women with psoriatic arthritis (PsA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results